Abstract : Human intestinal absorption (HIA) will dictate biopharmaceutical performance through its influence on absorption, distribution, metabolism, and elimination and can vary significantly Furthermore, 4 additional drugs were then analyzed using the developed equation and found to match well with literature, confirming the suitability of the method. Using a simple, economic, and robust UV bile salt assay allows prediction of HIA and avoids many of the disadvantages of other techniques, such as animal-based methods.
Introduction
Human intestinal absorption (HIA) is the mechanism through which drugs traverse from the intestine into the bloodstream. The vast majority of active pharmaceutical ingredients are administered orally; thus, it is essential that they are absorbed within the intestine to reach the intended site of action. Although it is possible to measure the percent HIA (% HIA) during clinical studies, it is far more useful to be able to predict the value much earlier on during drug development. It is for this reason that a significant amount of research has been undertaken in an attempt to develop a reliable, robust, and accurate method to predict % HIA.
Several different predictive approaches have been undertaken, including computational (in silico)
methods, 1,2 such as quantitative structure-activity relationships 3,4 and physiologically based pharmacokinetic modelling. 5 These techniques have a clear advantage in that they remove the need for costly laboratory-based experi-mental measurement yet their predictive ability can be limited.
In vitro models for the prediction of absorption include the application of dissolution analysis, 6 chromatographic analysis, 7 and dynamic gastric models. 8 Many of these in vitro models have included the presence of physiologically relevant solvent compo-sitions, mainly because it is known that solvent composition dictates intestinal drug solubility which, in turn, is an important factor in determining the rate, and extent, of absorption. 9 The specific components within human intestinal fluids that dramati-cally alter drug solubility are bile salts. The main biological function of bile salts is to solubilize lipids and vitamins in the intestine with a similar effect encountered for orally administered drugs. For a full review of the absorption-enhancing effects of bile salts. 10
In humans, the composition of bile salts is rather complex and for the purposes of this study was simplified to consider 1 bile salt in particular, namely sodium deoxycholate (NaDC). NaDC is a wellcharacterized amphiphilic molecule which can undergo micellar aggregation, 11,12 stabilized by polar interactions, 13 with comparatively small aggregation numbers as a result of the rigid molecular structure. 14 Previous research within our group has shown that NaDC, when in the presence of drugs, will exhibit modified physicochemical properties, for example, a variable (drug-specific) reduction in critical micellar
concentration. 15
When quantifying (or comparing) enhancement in solubility for a specific drug, or series of drugs, it is possible to evaluate the solubilization ratio (SR), where SR is equal to the moles of drug solubilized per mole of bile salt. One study in particular calculated SR for a series of steroids and then used these data to calculate micelle/water partition coefficients (Km/w) which were then correlated with octanol/water partition coefficients (Po/w). 16 Using this same theory as a basis for drug-NaDC measurement, this article describes the evolution of measuring SR and then using these values as the basis to form an equation to permit prediction of % HIA, thereby presenting an in vitro method to predict in vivo behavior.
Materials and Methods

Materials
Aqueous solutions of NaDC (97%), used as purchased from Sigma-Aldrich (Dorset, UK), were prepared by dilution from a 20 mM stock solution with distilled water as necessary to achieve concentrations of 7, 9, 11, 13, 17, and 20 mM (i.e., always at con-centrations greater than the stable micelle critical micellar concentration of NaDC 12 ). The following 24 compounds considered in this work were used as purchased: acetaminophen (99%; Sigma-Aldrich), acetyl salicylic acid (99%; Acros Organics, Geel, Belgium), alprenolol (98%; Sigma-Aldrich), amitriptyline (98%; Sigma-Aldrich), carbamazepine (99%; Sigma-Aldrich), cimetidine (Sigma-Aldrich), diclofenac (98%; TCI Europe, Zwijndrecht, Belgium), diphenhydramine (98%; TCI Europe), fenoprofen (97%; Fluka, Dorset, UK), fluconazole (98%; Sigma-Aldrich), flurbiprofen (98%; TCI Europe), gemfibrozil (98%; TCI Europe), ibuprofen (98%; BASF, Cheshire, UK), indomethacin (99%; Sigma-Aldrich), ketoprofen (98%; Sigma-Aldrich), lidocaine (98%, Sigma-Aldrich), mannitol (98%; Sigma-Aldrich), meloxicam (98%; TCI Europe), naproxen (98%; Sigma-Aldrich), phenylbutazone (99%; Sigma-Aldrich), piroxicam (98%, Sigma-Aldrich), propranolol (99%; Sigma-Aldrich), quinine (96%; Fluka), and terbutaline (96% Sigma-Aldrich). All experimental work was conducted without altering the pH or ionic strength to avoid the formation of a surfactant-gel hydropolymer. into it. The final model was obtained by excluding molecular de-scriptors which were not statistically significant (p value > 0.05), and those with unacceptably high levels of variance inflation factor, which is considered as a multicollinearity indicator, were not included in the final model. Cook's distance and residuals were used to detect whether any of the model variables had high leverage. The optimal final model was then obtained including only logKxm/a as a predictor for logit HIA, and the model was then validated using 4 compounds.
Results and Discussion
In total, 24 drugs were analyzed to determine the concentration of drug in solution as a function of NaDC concentration; these were selected to cover a range of physicochemical properties, such as reported HIA, log Po/w, and other properties. All data were then plotted to determine a SR value for each drug (i.e., the slope), a selection of which can be seen in Figure 1 . Figure 1 clearly shows a linear relationship between the con-centration of drug and the concentration of NaDC. Only linear sections of the plots were incorporated to calculate SR, some were deemed to be nonlinear, such as the lower concentrations of qui-nine and the higher concentrations of acetaminophen (data not shown). These nonlinear relationships may be due to preferential drugdrug interactions rather than drug-NaDC interactions as suchdrugs are known to self-associate. 19 The majority of the compounds did exhibit a linear relationship over the concentration range studied (7-20 mM), ensuring confidence in the experimental sys-tem. Using the calculated SR value, along with the mole fraction of aqueous solubility for the drug, facilitated calculation of a micelle/ aqueous partition coefficient for each drug.
Analyzing these values alongside reported % HIA literature data (Table 1) Using data presented in Table 1 , simple linear regression analysis was used to create an optimized equation to predict HIA:
The p values obtained for this model indicate that the relationship between % HIA and logKxm/a values was statistically significant at the 95% confidence level where they were <0.05, and the model's F-ratio was found to be statistically significant. Also, logKxm/a was found to have a 95% confidence interval of 0.365-0.558 and a t- Table 2 including validation compounds.
A plot of calculated % HIA with corresponding literature values can be seen in Figure 2 .
Conclusions
Overall, the development of an equation to predict % HIA using a simple UV-based technique via calculation of the micelle/water partition coefficient has been shown to be statistically appropriate and reliable as a method to determine intestinal absorption. Using a simple, economic, and robust UV bile salt assay allows prediction of HIA and avoids many of the disadvantages of other techniques, such as animal-based methods.
